Cargando…
Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is an idiopathic and chronic disorder that includes ulcerative colitis (UC) and Crohn’s disease (CD). Both diseases show an uncontrolled intestinal immune response that generates tissue inflammation. Dendritic cells (DCs) are antigen-presenting cells that play a key...
Autores principales: | Soleto, Irene, Fernández-Tomé, Samuel, Mora-Gutiérrez, Irene, Baldan-Martin, Montserrat, Ramírez, Cristina, Santander, Cecilio, Moreno-Monteagudo, José Andrés, Casanova, María José, Casals, Fernando, Casabona, Sergio, Becerro, Irene, Chaparro, María, Bernardo, David, Gisbert, Javier P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405461/ https://www.ncbi.nlm.nih.gov/pubmed/36009431 http://dx.doi.org/10.3390/biomedicines10081885 |
Ejemplares similares
-
Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn’s Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation
por: Baldan-Martin, Montse, et al.
Publicado: (2023) -
Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease
por: Soleto, Irene, et al.
Publicado: (2023) -
Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease
por: Fernández-Tomé, Samuel, et al.
Publicado: (2019) -
Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?
por: Gisbert, Javier P., et al.
Publicado: (2021) -
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)